The current measles outbreak has gripped US states like Texas and New Mexico leaving people worried whether it would become a new pandemic. According to the Texas Department of State Health Services as of February 21, 90 cases were diagnosed in the last month in the South Plains area, with at least 77 of them were reported in children and teens under 17.

Measles is highly contagious and can be deadly. The outbreak, which started spreading in late January, has resulted in multiple hospitalizations, with at least nine confirmed cases and three probable cases as of early February. Health officials caution that at least one in five infected individuals will have to be hospitalized, highlighting the severity of the situation.

Misinformation surrounding vaccines and with the new Trump administration anti-vaccine campaigs, has causing parents to hesitate or refuse vaccination.

Furthermore, the country down under Australia is also witnessing a surge in measles cases as health officials in Sydney have issued an urgent alert, urging residents to watch for measles symptoms after an infected individual visited several places in Sydney over the last seven days.

Authorities report that the traveller had returned from South East Asia where there are ongoing outbreaks of measles.

What Are The Symptoms Measles?

Key symptoms of measles include fever, a runny nose, sore eyes, and a cough. Typically, a red, blotchy rash appears three to four days later, spreading from the head down to the body. Symptoms can manifest between 7 and 18 days after exposure.

Anyone who experiences these symptoms after potential exposure should immediately contact their doctor or emergency department. It is crucial to call ahead before visiting to avoid potentially exposing others in the waiting room. Dr. Selvey also highlighted that ongoing measles outbreaks are occurring in various parts of the world, making awareness and prompt action essential.

Why It Is Important To Get Vaccinated?

According to CDC everyone should get the MMR vaccine. It protects you from measles, mumps, and rubella. Getting vaccinated helps stop these diseases from spreading. There are two safe MMR vaccines available. They work the same way, so it doesn't matter which one you get. Kids can also get a shot that protects against chickenpox too, but this is only for children.

Who Should Get Vaccinated?

Kids Need Two Shots

All children should get two MMR shots. The first shot should be given when they are between 12 and 15 months old. The second shot should be given when they are between 4 and 6 years old. If needed, the second shot can be given earlier, but it must be at least 28 days after the first shot.

College Students Need to Be Protected

Students going to college or other schools after high school, need two shots if they are not already immune. The shots must be at least 28 days apart.

Adults Need at Least One Shot

Most adults need at least one MMR shot. Some adults need two shots, especially those who work in healthcare, travel a lot, or go to college. These people should get two shots, with 28 days between them.

Travelers Need to Be Extra Careful

Anyone traveling to other countries should make sure they are protected. Babies 6 to 11 months old should get one shot before traveling. Kids 12 months and older, teens, and adults need two shots, with 28 days between them.

Healthcare Workers Must Be Immune

People who work in healthcare should have proof that they are immune to measles, mumps, and rubella. If they are not immune, they need two MMR shots, spaced 28 days apart.

Women Thinking About Having Babies

Women who might get pregnant should talk to their doctor about the MMR vaccine. It's safe to get the shot while breastfeeding.

Amid the growing burden of Non-Communicable Diseases (NCDs), India’s Union Ayush Ministry has launched yoga protocols that will target vulnerable groups with diabetes, high blood pressure, and asthma.

The “Yoga Protocol for Non-Communicable Diseases (NCDs) and Target Groups” is a significant push towards reshaping the country’s healthcare narrative from treatment to prevention, PTI reported.

NCDs such as diabetes, hypertension, cardiovascular ailments, chronic respiratory conditions, and mental health disorders are increasing significantly in the country. These also account for about 60 percent of all deaths in the country, signaling a clear need to focus on preventing the lifestyle-driven illnesses.

Also Read: IPL 2026: Rohit Sharma's Transformation Impresses Nita Ambani; Fitness Secrets Revealed

Prataprao Jadhav, Union Minister of State (Independent Charge) for Ayush, noted that prevention of these conditions is important for the better health of the nation, and yoga is India’s answer to the rising burden of lifestyle diseases.

“Through these evidence-based protocols, we are empowering every citizen to take charge of their own health and well-being in a simple, accessible, and sustainable manner. By integrating yoga into daily life, we aim to shift the focus from illness to wellness, reducing long-term healthcare pressures,” he said.

“This initiative reflects our commitment to building a healthier nation through holistic, preventive, and people-centric approaches rooted in India’s rich traditional knowledge,” the minister added.

What Are The Protocols?

It is part of the Yoga Mahotsav 2026, launched earlier this month by Union Ayush Minister Prataprao Jadhav, developed by the World Health Organization (WHO).

The protocols are designed as structured, evidence-based modules that integrate Yogic practices into daily life in a simple, accessible, and scalable manner.

The initiative has specific yoga interventions curated for major health conditions such as:

• diabetes — improving metabolic balance and glycemic control;
• hypertension — calming the nervous system and regulating blood pressure;
• bronchial asthma — strengthening respiratory capacity and improving lung function
• emotional well-being — breathing and meditation aimed at reducing stress, anxiety, and depression.

Further, it includes

• playful yoga modules for young children
• mental health-focused routines for adolescents,
• mobility-enhancing practices for the elderly
• specialized guidelines for women and pregnant mothers.

Yoga 365

The Ministry of Ayush has also launched Yoga 365 — a nationwide campaign to make yoga an integral part of citizens' daily lives — that goes beyond the International Day of Yoga (IDY), marked annually on June 21 worldwide.

According to the National Sample Survey (NSS), awareness of traditional systems like yoga stands at 95 percent in rural India and 96 percent in urban India.

The NSS also found that in around 1.1 crore households in rural India and around 1.4 crore households in urban India, at least one household member regularly practices yoga.

The Yoga 365 campaign aims to

• mobilize communities through mission-mode outreach,
• promote behavior change,
• integrate yoga into diverse spaces—from schools and offices to neighborhood groups and digital platforms.

The Morarji Desai National Institute of Yoga, under the Ministry of Ayush, has also signed a Memorandum of Understanding with the wellness platform Habuild to offer free daily online yoga sessions.

The COVID-19 BA.3.2 strain, nicknamed Cicada Variant, is spreading rapidly in the US, raising the possibility of becoming the dominant strain in the country, according to experts.

The US Centers for Disease Control and Prevention (CDC), in its latest report, has raised concerns about BA.3.2 — a highly mutated variant of COVID.

BA.3.2 has already been reported in at least 23 countries, including 25 states in America, as per the report. It has also been detected in 132 wastewater samples from Massachusetts.

The 25 states include California, Connecticut, Florida, Hawaii, Idaho, Illinois, Louisiana, Maine, Michigan, Maryland, Massachusetts, Missouri, New Hampshire, New Jersey, Nevada, New York, Ohio, Pennsylvania, Rhode Island, South Carolina, Texas, Utah, Vermont, Virginia, and Wyoming.

"Cicada can become the dominant strain in the US,” Dr. Robert H. Hopkins Jr., medical director of the National Foundation for Infectious Diseases, told USA TODAY.

While it is not certain, it can also "drive a US summer surge.”

The CDC warned that a new variant "with substantial capacity to evade immunity from previous infections or vaccines could be associated with seasonal increases in COVID-19 activity.”

In the US, COVID-19 is still linked to roughly 300 to 500 deaths per week, according to recent data based on provisional estimates from the CDC.

Brandon Dionne, an associate clinical professor of pharmacy and health systems sciences at Northeastern University, stated that the virus may evolve and increase the possibility of more severe disease.

“It’s something we definitely want to monitor,” Dionne said. “It could, over time, become the dominant strain in the US, but it’s not yet there," he said.

Also read: COVID Variant BA.3.2 Spreads To 23 Countries: Is The Variant Under Monitoring A Cause Of Worry?

What Is The Cicada COVID Variant?

Cicada was first identified in a respiratory sample in South Africa in November 2024.

It is a descendant of the Omicron BA.3 lineage, and is genetically distinct from the previously circulating JN.1 lineages (including LP.8.1 and XFG).

BA.3.2 comprises two major branches, BA.3.2.1 and BA.3.2.2. BA.3.2.2 also has substitutions like: K356T, A575S, R681H, and R1162P.

The World Health Organization (WHO) has designated BA.3.2 as a Variant Under Monitoring (VUM). It means the variant may not be that dangerous yet, but it may have concerning mutations.

The CDC’s latest Morbidity and Mortality Weekly Report explains that Cicada has “70 to 75 substitutions and deletions in the gene sequence of its spike protein”.

Also read: Maternal Vaccination During Pregnancy Can Prevent COVID-related Hospitalization In Babies: Study

Will Current COVID Vaccines Work?

The variant is particularly concerning as it provides no immune protection to people with previous infection or even vaccination.

“The number of mutations from JN.1 viruses makes it less likely that the current vaccines will be highly effective against Cicada, but we need more data to better answer this question,” Dr. Hopkins Jr. said.

However, according to the WHO, current COVID vaccines are expected to continue protecting against severe disease. Moreover, the WHO said BA.3.2 doesn’t seem to be making people sicker so far and hasn’t resulted in increased hospitalizations and deaths.

Common symptoms of Cicada variant include:

• Cough
• Fever or chills
• Sore throat
• Congestion
• Shortness of breath
• Loss of smell or taste
• Fatigue
• Headache.

The Italian authorities this week have confirmed the first human case of H9N2 Avian Flu in the Lombardy region – also the first in the European Union.

The influenza A(H9N2) infection was identified in a traveler returning from a non-European country, where the virus has previously been identified in birds. The patient has coexisting medical conditions and is currently receiving medical treatment in a hospital.

Italy’s Ministry of Health, in a statement, said that they identified “infection with the low-pathogenicity avian influenza A (H9N2) virus of animal origin, in a frail person with concomitant illnesses, who came from a non-European country where he contracted the infection, and is currently hospitalized”.

Public health authorities in the country have performed contact tracing as a precaution to identify and control possible onward transmission and have initiated several epidemiological and microbiological investigations.

“All the required checks were promptly carried out, and the relevant contacts were identified, as part of the ordinary prevention and surveillance activities. Currently, no critical issues have been identified, and the situation is being constantly monitored,” the Ministry said.

What is H9N2?

H9N2 is a subtype of the avian influenza A virus (bird flu) that causes respiratory illness in poultry worldwide and is endemic in many parts of Asia, Africa, and the Middle East.

While low-pathogenic in birds, it sporadically infects humans—usually children—causing mild, influenza-like illness, though severe cases can occur.

According to the WHO, most human cases of infection with avian influenza A(H9N2) viruses are exposed to the virus through contact with infected poultry or contaminated environments.

Also read: Japan Confirms New Highly Pathogenic Bird Flu Outbreak: Report

Human infection tends to result in mild clinical illness. However, globally, there have been some hospitalized cases and two fatal cases reported in the past.

“Based on available information, further sporadic human cases could occur as this virus is one of the most prevalent avian influenza viruses circulating in poultry in different regions. With the currently available evidence, the WHO assesses the current public health risk to the general population posed by this virus as low,” the WHO said.

Human bird flu cases have been reported in countries like China, India, the UK, and Vietnam, often resulting in full recovery.

Also read: UK Reports Its First Human Case Of Bird Flu

Rising Global Bird Flu Cases: Are Humans At Threat

Globally, the spread of bird flu cases has been driven by migratory birds, with increasing outbreaks in poultry farms across Japan, India, South Korea, and the US, among others.

To date, most human cases have occurred in people handling infected poultry or animals.

Key Symptoms of bird flu in humans include:

Cough,

sore throat,

runny or stuffy nose,

difficulty breathing

High fever (often >38°C),

fatigue,

muscle/body aches

Conjunctivitis (red/irritated eyes),

nausea,

vomiting,

diarrhea.

In severe cases, pneumonia and Acute Respiratory Distress Syndrome (ARDS), have been reported.

Human infections remain rare, and the risk is also low, yet scientists say that the virus may someday evolve into a variant that can cause significant harm to humans. Recent infections in mammals (like cattle) increase concern.

Bird flu (H5N1) was detected in the US milk supply, particularly in raw milk from infected dairy cows, with high levels found in milk and udder tissues.

“There is a consensus among those who study how infectious diseases originate and spread that the next pandemic in humans is most likely to originate in a bird flu. Of the different types of bird flu that are especially important, H5N1 avian influenza is considered the most likely candidate for a spillover event, with a high fatality rate,” Dr. Gautam Menon, Professor of Physics & Biology, Ashoka University, told HealthandMe.

“From the small number of infections in humans that have been diagnosed, we know that about 30-40 percent of such cases can be fatal. But we don’t know the possible background of infections in which these deaths or serious cases might occur. In particular, the possibility of asymptomatic infections is open,” he added.